Analyst Price Targets — ARDT
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| December 18, 2025 1:13 pm | — | UBS | $14.00 | $8.94 | TheFly | Ardent Health price target lowered to $14 from $14.50 at UBS |
| December 18, 2025 12:06 pm | Ann Hynes | Mizuho Securities | $12.00 | $8.94 | TheFly | Ardent Health price target lowered to $12 from $20 at Mizuho |
| November 18, 2025 11:51 am | — | Mizuho Securities | $13.00 | $8.70 | TheFly | Ardent Health price target lowered to $13 from $20 at Mizuho |
| November 14, 2025 8:59 pm | Whit Mayo | Leerink Partners | $16.00 | $9.01 | TheFly | Ardent Health price target lowered to $16 from $23 at Leerink |
| November 14, 2025 1:30 pm | — | Truist Financial | $13.00 | $8.92 | TheFly | Ardent Health price target lowered to $13 from $21 at Truist |
| November 14, 2025 1:27 pm | Ben Hendrix | RBC Capital | $16.00 | $8.97 | StreetInsider | Ardent Health Partners Inc (ARDT) PT Lowered at RBC Capital Amid Near-Term Headwind |
| November 14, 2025 10:11 am | — | Morgan Stanley | $12.00 | $9.30 | TheFly | Ardent Health downgraded to Equal Weight from Overweight at Morgan Stanley |
| October 14, 2025 9:02 am | — | Goldman Sachs | $19.00 | $14.13 | TheFly | Ardent Health initiated with a Neutral at Goldman Sachs |
| September 10, 2025 9:02 am | — | UBS | $17.00 | $13.03 | TheFly | Ardent Health initiated with a Buy at UBS |
| March 4, 2025 12:57 pm | — | RBC Capital | $21.00 | $15.03 | TheFly | Ardent Health price target lowered to $21 from $23 at RBC Capital |
Latest News for ARDT
NEW YORK, March 02, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Ardent Health, Inc. ("Ardent Health, Inc." or the "Company") (NYSE: ARDT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Ardent Health, Inc. investors who were adversely affected by alleged securities fraud between July 18, 2024 and November 12, 2025.
SAN FRANCISCO, March 02, 2026 (GLOBE NEWSWIRE) -- National shareholder rights law firm Hagens Berman is notifying investors in Ardent Health, Inc. (NYSE: ARDT) regarding the March 9, 2026, lead plaintiff deadline in a pending securities class action the company and certain of its top executives. CLICK HERE TO SUBMIT YOUR ARDT LOSSES The litigation focuses on the revelation in Nov. 2025 that Ardent alleged utilized a…
LOS ANGELES, March 02, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Ardent Health, Inc. (“Ardent” or “the Company”) (NYSE: ARDT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the…
LOS ANGELES, March 02, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming March 9, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Ardent Health, Inc. (“Ardent” or the “Company”) (NYSE: ARDT) securities between July 18, 2024 and November 12, 2025, inclusive (the “Class Period”). IF YOU…
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Ardent To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Ardent between July 18, 2024 and November 12, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for ARDT.
U.S. House Trading
No House trades found for ARDT.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.